rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2009-11-25
|
pubmed:abstractText |
In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1534-6080
|
pubmed:author |
pubmed-author:AlbertazziAlbertoA,
pubmed-author:BartezaghiMartaM,
pubmed-author:BerlocoPasqualeP,
pubmed-author:BertoniElisabettaE,
pubmed-author:BusnachGhilG,
pubmed-author:CitterioFrancoF,
pubmed-author:CorbettaGiuseppeG,
pubmed-author:CossuMariaM,
pubmed-author:Dal CantonAntonioA,
pubmed-author:FedericoStefanoS,
pubmed-author:GoepelVolkerV,
pubmed-author:GubbiottiGiampieroG,
pubmed-author:MessaPiergiorgioP,
pubmed-author:MontanaroDomenicoD,
pubmed-author:PireddaGianbenedettoG,
pubmed-author:PisaniFrancescoF,
pubmed-author:PonticelliClaudioC,
pubmed-author:RigottiPaoloP,
pubmed-author:SalvadoriMaurizioM,
pubmed-author:ScolariMaria PieraMP,
pubmed-author:SparacinoVitoV,
pubmed-author:TisoneGiuseppeG,
pubmed-author:VerouxPierfrancescoP
|
pubmed:issnType |
Electronic
|
pubmed:day |
27
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1194-202
|
pubmed:meshHeading |
pubmed-meshheading:19935373-Adolescent,
pubmed-meshheading:19935373-Adult,
pubmed-meshheading:19935373-Aged,
pubmed-meshheading:19935373-Confidence Intervals,
pubmed-meshheading:19935373-Creatinine,
pubmed-meshheading:19935373-Cyclosporine,
pubmed-meshheading:19935373-Dose-Response Relationship, Drug,
pubmed-meshheading:19935373-Drug Therapy, Combination,
pubmed-meshheading:19935373-Humans,
pubmed-meshheading:19935373-Immunosuppressive Agents,
pubmed-meshheading:19935373-Kidney Transplantation,
pubmed-meshheading:19935373-Living Donors,
pubmed-meshheading:19935373-Middle Aged,
pubmed-meshheading:19935373-Patient Compliance,
pubmed-meshheading:19935373-Patient Selection,
pubmed-meshheading:19935373-Sirolimus,
pubmed-meshheading:19935373-Survival Analysis,
pubmed-meshheading:19935373-Treatment Outcome,
pubmed-meshheading:19935373-Triglycerides,
pubmed-meshheading:19935373-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.
|
pubmed:affiliation |
Renal Transplant Unit, Careggi University Hospital, Florence, Italy. salvadorim@aou-careggi.toscana.it
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|